ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,284Medicare Part D Prescriptions Filled, Including Refills

Rank: 219 out of 2035

$450K Total Retail Price of All Prescriptions

Rank: 383 out of 2035

192 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 192 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

29% of this provider’s 192 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 7,515 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
METOPROLOL TARTRATE 474 369 1 8
SIMVASTATIN 468 402 2 1
HYDROCODONE-ACETAMINOPHEN 397 333 S3 3 2
LISINOPRIL 274 220 4 3
WARFARIN SODIUM 256 228 5 11
FUROSEMIDE 253 236 6 7
AMLODIPINE BESYLATE 250 198 7 6
DONEPEZIL HCL 241 232 8 24
LEVOTHYROXINE SODIUM 211 182 9 4
HYDRALAZINE HCL 193 183 10 45
MIRTAZAPINE 191 181 11 46
LANTUS SOLOSTAR 189 179 12 66
CITALOPRAM HBR 189 166 12 20
POTASSIUM CHLORIDE 164 151 14 18
OMEPRAZOLE 142 115 15 5
LACTULOSE 128 117 16 96
NAMENDA 119 102 17 37
NOVOLOG FLEXPEN 103 60 18 133
TAMSULOSIN HCL 101 100 19 25
CLOPIDOGREL 101 79 19 30
RISPERIDONE 98 87 21 68
FENTANYL 98 75 S2 21 53
LEVETIRACETAM 97 59 23 87
GABAPENTIN 90 44 24 14
PANTOPRAZOLE SODIUM 83 64 25 42
VALPROIC ACID 80 67 26 235
TRAMADOL HCL 80 57 26 19
NOVOLOG 74 56 28 95
PREDNISONE 71 67 29 36
PLAVIX 70 56 30 49
CARVEDILOL 69 67 31 22
LANTUS 68 34 32 40
RANITIDINE HCL 67 50 33 28
METFORMIN HCL 66 49 34 9
CLONIDINE HCL 65 54 35 61
DIOVAN 65 65 35 76
PHENYTOIN 64 62 37 268
BACLOFEN 63 37 38 112
ALBUTEROL SULFATE 62 59 39 90
BRIMONIDINE TARTRATE 61 39 40 239
PRAVASTATIN SODIUM 61 37 40 17
MEGESTROL ACETATE 54 54 R 42 175
NIFEDIPINE ER 54 54 42 98
LATANOPROST 52 30 44 177
ISOSORBIDE MONONITRATE ER 51 32 45 32
CALCIUM ACETATE 51 35 45 251
SANTYL 50 37 47 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.